Lymphoma Clinical Trials
Lymphoma clinical trials provide ways for patients to access some of the newest and most innovative therapies before those therapies are made available at other hospitals and cancer centers. Clinical trials are typically conducted to compare a new treatment option to the existing “best standard” of care, which can help researchers determine if the new therapy has the potential to be more effective (or cause fewer side effects) than other options that are currently being used. The results of these important trials can help researchers improve treatment options, survival rates and quality of life for current and future lymphoma patients.
Moffitt Cancer Center’s clinical trial program is one of the most robust in the region, conducting numerous studies that focus on both Hodgkin and non-Hodgkin lymphoma. Our lymphoma clinical trials give patients opportunities to access:
- Novel chemotherapy drugs and combinations
- Highly targeted radiation therapy delivery techniques
- Innovative antibiotic and vaccination therapies
- Treatment options for recurrent lymphomas
- Treatment options for each specific lymphoma subtype
Moffitt’s lymphoma clinical trials are conducted by experienced researchers and oncologists. Each patient’s progress is continually monitored to ensure that he or she is responding optimally to the recommended treatment. Furthermore, participants are carefully screened for each trial based on individualized factors such as cancer type and age; this increases the likelihood that a patient will benefit more from the specific treatment being tested than the other options that are currently available. And, adaptations can be made to a patient’s treatment plan at any time.
Because of our dedication to conducting groundbreaking research and advancing lymphoma treatment, we have been named a Comprehensive Cancer Center by the National Cancer Institute. We are the only cancer center based in Florida to have received this prestigious recognition.
For more information about Moffitt Cancer Center’s lymphoma clinical trials, call 1-888-663-3488 or submit a new patient registration form online. We can determine if any of our ongoing studies are appropriate for you. No referral is needed to reach out to Moffitt Cancer Center.